Back

Validation of the CARPREG II risk stratification model and the WHOm scale in pregnant women with heart disease

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Pregnancy and Cardiovascular Disease ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Miss Diana Botero

University of Antioquia, Medellin (Colombia)

187 More presentations in this session

Presentation thumbnail
The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
Professor J. McMurray (Glasgow, GB)
Abstract Slides
Presentation thumbnail
CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation
Doctor C. Su (Taichung, TW)
Abstract Slides
Presentation thumbnail
Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study
Doctor T. Rhee (Seoul, KR)
Abstract Slides
Presentation thumbnail
Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry
Professor W. Shimizu (Matsudo, JP)
Abstract Slides
Presentation thumbnail
The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.
Doctor S. Alampoondi Venkataramanan (Worcester, US)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Disease in Special Populations ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Pregnancy in congenital heart disease - risk stratificaton
3 September 2019
thumbnail
Congress Presentation
A systematic review of risk prediction models for incident heart failure in the community
22 May 2023
thumbnail
Congress Presentation
Risk assessment using DEVI and CARPREG -1 score to predict maternal adverse cardiac cvents in pregnancies with valvular heart disease: external validation study from MPAC registry
31 August 2024
thumbnail
Congress Presentation
Predictive variables of post-pregnancy hypertension in patients with no previous hypertensive history after hypertensive disorders of pregnancy: a prospective study in Argentina
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources